The benefits of clopidogrel in the treatment and prevention of coronary artery disease vary among patients. Studies have identified predictive markers of poor response to clopidogrel that might allow risk stratification of patients. are we ready to enter the age of personalized medicine?
|Number of pages||3|
|Journal||Nature Reviews Cardiology|
|State||Published - May 2009|